Hhlr Advisors, Ltd. 13F holdings, Q2 2025
Holdings as of June 30, 2025 · filings on SEC EDGAR · latest filing →
Hhlr Advisors, Ltd. disclosed 36 US equity positions worth $3.1bn in its Q2 2025 13F filing. The largest position was PDD at 23.5% of the reported book, followed by FUTU and WEBULL CORP. Against the Q1 2025 filing, it opened 2 new positions, added to 1 and reduced 9 among the top 36 holdings.
What did Hhlr Advisors, Ltd. own in Q2 2025? Top 36 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs Q1 2025 |
|---|---|---|---|---|---|---|---|
| 1 | PDD PDD HOLDINGS INC | Consumer Cyclical | 23.5% | $730.2m | 6,976,804 | 6% | added |
| 2 | FUTU FUTU HLDGS LTD | Financial Services | 17.2% | $532.9m | 4,312,237 | 0% | held |
| 3 | WEBULL CORP | 12.7% | $395.6m | 33,080,846 | – | new | |
| 4 | ONC BEONE MEDICINES LTD | Healthcare | 8.1% | $250.4m | 1,034,306 | 0% | held |
| 5 | NTES NETEASE INC | Communication Services | 7.2% | $223.9m | 1,663,668 | -38% | reduced |
| 6 | LEGN LEGEND BIOTECH CORP | Healthcare | 6.8% | $212.4m | 5,984,550 | 0% | held |
| 7 | BEKE KE HLDGS INC | Real Estate | 4.3% | $132.4m | 7,465,465 | -38% | reduced |
| 8 | BABA ALIBABA GROUP HLDG LTD | Consumer Cyclical | 4.2% | $130.4m | 1,149,700 | -71% | reduced |
| 9 | AVBP ARRIVENT BIOPHARMA INC | 3.1% | $97.6m | 4,484,672 | 0% | held | |
| 10 | WNS HLDGS LTD | 3.1% | $96.8m | 1,531,466 | 0% | held | |
| 11 | JD JD.COM INC | Consumer Cyclical | 2.4% | $74.3m | 2,275,500 | -53% | reduced |
| 12 | YSG YATSEN HLDG LTD | 1.9% | $58.9m | 6,111,933 | -11% | reduced | |
| 13 | CWAN CLEARWATER ANALYTICS HLDGS I | Technology | 1.0% | $30.0m | 1,365,971 | – | new |
| 14 | CTKB CYTEK BIOSCIENCES INC | Healthcare | 0.7% | $22.6m | 6,657,030 | 0% | held |
| 15 | VIPS VIPSHOP HLDGS LTD | Consumer Cyclical | 0.5% | $17.0m | 1,131,788 | -83% | reduced |
| 16 | LI LI AUTO INC | Consumer Cyclical | 0.5% | $16.8m | 620,000 | 0% | held |
| 17 | NBP I MAB | Healthcare | 0.5% | $14.5m | 5,980,568 | 0% | held |
| 18 | ZTO ZTO EXPRESS CAYMAN INC | Industrials | 0.4% | $11.9m | 671,387 | 0% | held |
| 19 | BZ KANZHUN LIMITED | Communication Services | 0.3% | $10.3m | 576,339 | 0% | held |
| 20 | API AGORA INC | Technology | 0.3% | $8.0m | 2,098,553 | 0% | held |
| 21 | GOSS GOSSAMER BIO INC | Healthcare | 0.2% | $6.1m | 4,974,041 | 0% | held |
| 22 | MAZE MAZE THERAPEUTICS INC | 0.2% | $5.6m | 457,535 | 0% | held | |
| 23 | SGMT SAGIMET BIOSCIENCES INC | Healthcare | 0.2% | $5.5m | 724,800 | 0% | held |
| 24 | EM SMART SH GLOBAL LTD | 0.1% | $4.5m | 3,949,700 | 0% | held | |
| 25 | TUYA TUYA INC | 0.1% | $3.6m | 1,564,400 | 0% | held | |
| 26 | CTNM CONTINEUM THERAPEUTICS INC | 0.1% | $2.7m | 669,337 | 0% | held | |
| 27 | MOGU MOGU INC | 0.1% | $1.8m | 847,510 | 0% | held | |
| 28 | BEDU BRIGHT SCHOLAR ED HLDGS LTD | 0.1% | $1.7m | 988,143 | 0% | held | |
| 29 | GE GE AEROSPACE | Industrials | 0.1% | $1.6m | 6,305 | -7% | reduced |
| 30 | MCO MOODYS CORP | Financial Services | 0.0% | $1.2m | 2,476 | -6% | reduced |
| 31 | MSCI MSCI INC | Financial Services | 0.0% | $1.2m | 2,008 | -6% | reduced |
| 32 | PACB PACIFIC BIOSCIENCES CALIF IN | Healthcare | 0.0% | $1.1m | 918,892 | 0% | held |
| 33 | ALGS ALIGOS THERAPEUTICS INC | 0.0% | $549.7k | 76,247 | 0% | held | |
| 34 | LAKESHORE BIOPHARMA CO LTD | 0.0% | $76.7k | 75,179 | 0% | held | |
| 35 | UXIN UXIN LTD | 0.0% | $70.5k | 19,156 | 0% | held | |
| 36 | RIDGETECH INC | 0.0% | $22.2k | 20,167 | 0% | held |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.